about
Antiepileptic drugs and bone metabolismPhenobarbital withdrawal seizures may occur over several weeks before remitting: human data and hypothetical mechanism.Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.Rational Polytherapy with Antiepileptic Drugs.The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.Vitamin D in health and disease: current perspectives.Resurgence of vitamin D: Old wine in new bottleOsteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D₃ function in human colon adenocarcinoma LS180 cells.Antiepileptics and bone health.Maintaining strong bones: strong opinions, little evidence.Induction of endogenous pathways by antiepileptics and clinical implications.Optimizing antiepileptic drug therapy in the elderly.Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with EpilepsyInterplay between vitamin D and the drug metabolizing enzyme CYP3A4Epilepsy-related injuries.Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalaciaWomen and epilepsy: review and practical recommendations.Role of vitamin d in cardiometabolic diseasesScreening bone mineral density in epilepsy: a call to action, but what action?Treatment and management of epilepsy in the elderly demented patient.Antiepileptic drug use and rates of hip bone loss in older men: a prospective study.Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation.The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism.Possible methods for the prevention of bone loss in persons with epilepsy.Bone loss associated with use of antiepileptic drugs.Advantages of cell-based high-volume screening assays to assess nuclear receptor activation during drug discovery.Use of phenytoin for the long-term treatment of partial seizures: Results of a survey conducted during the 2004 meeting of the American Academy of Neurology.Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.May long term oxcarbazepine treatment be lead to secondary hyperparathyroidism?Bilateral femoral neck fractures resulting from a grand mal seizure in an elderly man with Down syndromeA 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy.[Vitamin D deficiency in adults: to better understand a new presentation of an old disease].The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.Bone Health in Patients with Epilepsy: A Community-based Pilot Nested Case-control Study.Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.Evaluation of bone health among epileptic patients using biochemical markers and DEXA scan: an Egyptian study
P2860
Q21245075-692CA559-1B64-4A09-A733-A23CBBB49476Q31167774-E220EE92-DB8C-446B-B4C8-9F42D4061F3FQ33290977-D1A427ED-100E-4ACB-A81A-26A7FE7C970BQ33664046-CF19D488-BA87-41DA-87C5-A7CDFBA4AD5BQ34158012-ECB6E6EE-AF91-463F-897E-5F747DB1B6F6Q34481617-64ADEC50-C4A6-4BE4-9A6F-720791E95563Q35806866-BDC01A5A-48C6-4EE6-8F50-A1F6D455A81BQ35924416-E2B2CF29-02CB-430A-80FF-8229FEC8BBAAQ36024406-621A833B-DA38-4929-B8BB-02ACA39CE14AQ36059549-C99CBD58-CE7A-4274-8711-7591A09074A7Q36094650-C97AD564-747F-42B5-96E4-6AD4E826C310Q36263605-B74CAE51-F8B2-4E14-99CA-002432AC1CB0Q36270316-607E168C-53FF-4B7E-B640-A145B77C47C7Q36514350-C4C79C8B-38BA-45F6-900A-7C843CDD0393Q36545257-8C10F8D7-1C1E-4176-8DE0-EF60B21DD299Q36625022-324CFCD3-AF72-4C82-834E-95822242E66EQ36721536-C0CAC6BA-D59C-4B02-929A-AC822DBECCF4Q36752925-44DB0AFF-C952-449C-A0CB-7B4A33D32457Q36825786-6AA849FA-3C0A-42FE-968B-6B2891700F64Q37169769-7D288797-39C3-4B10-ADDE-FC75A26938F8Q37178698-A8DB0429-8BAD-4F6C-9B69-0B575012541FQ37178973-86BF0C5E-80CD-48B5-84D2-78F957380B0CQ37199090-992B87D0-03A7-496D-B39F-E5E9775273C2Q37400616-AA8A5C6B-7192-4C8C-B237-E7CF20889584Q37507951-D3D96F66-B89E-4CFF-9AC0-0B2F01D539CEQ37702229-3B5986CB-C828-40E4-B6F7-5B9BAC420F4CQ38211210-C7178C17-D2DE-4E05-9DC7-A5D8DD22EF00Q38472150-64061D3D-4374-460B-8624-171BDE724AEDQ39030320-0D0D089F-DE45-4D96-A11D-F3CD63D1DB6DQ40010387-B3E1268D-039C-4E4F-9A47-31D57CEF54B0Q40280788-8884733E-30F5-4E47-B91B-16E309397472Q42548087-C76FE2CC-5D85-42D4-A6BF-8534CB339A67Q42728438-54753C2F-1AF8-4777-85B6-7E8440C2546BQ43291757-3829B39C-3628-4CFD-831E-B24E940CE6F1Q46274259-98FE3672-226B-4408-A54D-EB2EB42CB9C5Q46293491-2B64C5C9-9960-4C42-8A32-E998F2583FC1Q47149393-68151059-3958-43A0-9A33-BCDCC479A446Q48429352-D4BA7530-20DD-4A35-BA08-9DFC5F116CA9Q51399526-7384C557-73A2-45C8-88C5-0C9AAB1F49BCQ56604475-831AB79F-F261-42D3-ABFD-F218D0D2C7FB
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Epilepsy and bone health in adults.
@ast
Epilepsy and bone health in adults.
@en
type
label
Epilepsy and bone health in adults.
@ast
Epilepsy and bone health in adults.
@en
prefLabel
Epilepsy and bone health in adults.
@ast
Epilepsy and bone health in adults.
@en
P1433
P1476
Epilepsy and bone health in adults.
@en
P2093
Alison M Pack
Martha J Morrell
P356
10.1016/J.YEBEH.2003.11.029
P478
P577
2004-02-01T00:00:00Z